OBJECTIVE: To examine health care workers' (HCWs') acceptance of and adherence to isoniazid preventive therapy in the setting of a comprehensive tuberculin skin-testing program. DESIGN: Descriptive case series. SETTING: University-affiliated inner-city public hospital in Atlanta, Ga. PARTICIPANTS: A total of 125 HCWs (91 hospital employees and 34 house staff or medical students [the physician group]) who had a positive tuberculin skin test between July 1992 and January 1994 and were offered isoniazid preventive therapy. INTERVENTIONS: Health care workers with a recent tuberculin skin test conversion were required to have a chest x-ray performed and see a physician and were encouraged but not required to undergo preventive therapy. MAIN OUTCOME MEASURES: Acceptance and initiation of preventive therapy with isoniazid by HCWs, completion of at least 6 months of preventive therapy, and differences between the employee and physician groups. RESULTS: All 125 HCWs with a recent positive tuberculin skin test had a chest radiograph performed, 123 (98.4%) saw a physician, and 105 (84%) initiated preventive therapy. Sixty-nine (66%) of the 105off HCWs who initiated preventive therapy (55% of the 125 total) completed at least 6 months of isoniazid therapy. More of the physician group than of the employee group completed preventive therapy (25 of 34 [74%] vs 44 of 91 [48%], respectively; P<.01). Of the 36 HCWs who started but did not complete preventive therapy, 12 discontinued therapy because of an adverse drug effect and 24 were nonadherent. CONCLUSIONS: Acceptance of tuberculosis preventive therapy by HCWs was high in the setting of a comprehensive tuberculin skin-testing program, and completion of therapy was much higher in the physician group than in previously reported series.
OBJECTIVE: To examine health care workers' (HCWs') acceptance of and adherence to isoniazid preventive therapy in the setting of a comprehensive tuberculin skin-testing program. DESIGN: Descriptive case series. SETTING: University-affiliated inner-city public hospital in Atlanta, Ga. PARTICIPANTS: A total of 125 HCWs (91 hospital employees and 34 house staff or medical students [the physician group]) who had a positive tuberculin skin test between July 1992 and January 1994 and were offered isoniazid preventive therapy. INTERVENTIONS: Health care workers with a recent tuberculin skin test conversion were required to have a chest x-ray performed and see a physician and were encouraged but not required to undergo preventive therapy. MAIN OUTCOME MEASURES: Acceptance and initiation of preventive therapy with isoniazid by HCWs, completion of at least 6 months of preventive therapy, and differences between the employee and physician groups. RESULTS: All 125 HCWs with a recent positive tuberculin skin test had a chest radiograph performed, 123 (98.4%) saw a physician, and 105 (84%) initiated preventive therapy. Sixty-nine (66%) of the 105off HCWs who initiated preventive therapy (55% of the 125 total) completed at least 6 months of isoniazid therapy. More of the physician group than of the employee group completed preventive therapy (25 of 34 [74%] vs 44 of 91 [48%], respectively; P<.01). Of the 36 HCWs who started but did not complete preventive therapy, 12 discontinued therapy because of an adverse drug effect and 24 were nonadherent. CONCLUSIONS: Acceptance of tuberculosis preventive therapy by HCWs was high in the setting of a comprehensive tuberculin skin-testing program, and completion of therapy was much higher in the physician group than in previously reported series.
Authors: Hyun Lee; Gun Woo Koo; Ji-Hee Min; Tai Sun Park; Dong Won Park; Ji-Yong Moon; Sang-Heon Kim; Tae Hyung Kim; Ho Joo Yoon; Jang Won Sohn Journal: Sci Rep Date: 2019-01-11 Impact factor: 4.379
Authors: Juana Sedamano; Alvaro Schwalb; Rodrigo Cachay; Carlos Zamudio; César Ugarte-Gil; Gabriela Soto-Cabezas; César V Munayco; Carlos Seas Journal: BMC Public Health Date: 2020-05-03 Impact factor: 3.295
Authors: Esther Arguello Perez; Susan K Seo; William J Schneider; Cynthia Eisenstein; Arthur E Brown Journal: Clin Infect Dis Date: 2017-11-29 Impact factor: 9.079